Insiders · Profile

Kim Lorence H.

Director at Revolution Medicines · Chief Financial Officer at Moderna. Filing since 6 Dec 2019. CIK 0001643746

RVMD Revolution Medicines, Inc. Director · 3 trades MRNA Moderna Chief Financial Officer · 15 trades

Company

Date

Role

Action

Shares

Amount

Of holding

RVMD Revolution Medicines, Inc.

8 Sep 2026

Director

Sold on a plan

17,090

$3.59M

100%

RVMD Revolution Medicines, Inc.

31 Aug 2026

Director

Sold on a plan

56,000

$11.38M

76.6%

RVMD Revolution Medicines, Inc.

22 Jul 2022

Director

Bought

50,000

$1.00M

476%

2 Jun 2020

Chief Financial Officer

Sold, plan not stated

241,000

$14.05M

16.7%

27 May 2020

Chief Financial Officer

Sold, plan not stated

241,000

$12.32M

16.7%

18 May 2020

Chief Financial Officer

Sold, plan not stated

241,000

$19.79M

16.7%

15 May 2020

Chief Financial Officer

Sold, plan not stated

20,000

$1.31M

1.6%

12 May 2020

Chief Financial Officer

Sold, plan not stated

241,000

$15.54M

16.5%

15 Apr 2020

Chief Financial Officer

Sold, plan not stated

20,000

$724.23K

1.6%

16 Mar 2020

Chief Financial Officer

Sold, plan not stated

20,000

$523.82K

1.6%

4 Mar 2020

Chief Financial Officer

Sold, plan not stated

20,000

$554.20K

1.6%

26 Feb 2020

Chief Financial Officer

Sold, plan not stated

18,652

$533.27K

1.4%

25 Feb 2020

Chief Financial Officer

Sold, plan not stated

1,348

$34.55K

0.1%

7 Feb 2020

Chief Financial Officer

Sold, plan not stated

33,295

$767.78K

2.5%

28 Jan 2020

Chief Financial Officer

Sold, plan not stated

900

$21.03K

0.1%

27 Jan 2020

Chief Financial Officer

Sold, plan not stated

23,805

$547.75K

1.7%

22 Jan 2020

Chief Financial Officer

Sold, plan not stated

2,000

$46.08K

0.1%

6 Dec 2019

Chief Financial Officer

Sold, plan not stated

238,532

$4.77M

14.9%

18 decisions on file.